Safety and Preliminary Efficacy of HN2302 in Patients With Autoimmune Diseases

Clinical trial NCT07523282 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07523282
Sponsor: Shenzhen MagicRNA Biotechnology Co., Ltd
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Autoimmune Disease Systemic Lupus Erythematosus Systemic Sclerosis (SSc)

Start date: 2026-12-31
Primary completion: 2027-12-31
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.